Blog

Photo: Depositphotos

Apr 15, 2025, 09:37

ALK Positive lung cancer community

ALK Positive posted on LinkedIn:

“ALK-positive lung cancer community

With your help, we can find ALK+ cancer research breakthroughs sooner – for people like Jenna, pictured here, and many others.

Please join the ALK Life Study – the largest global registry of ALK+ lung cancer. Your participation will help us improve the life expectancy and quality of life for ALK+ cancer patients worldwide.”

Read Further.

ALK Positive lung cancer community

ALK Life Study ALK Positive ALK+ lung cancer cancer OncoDaily Oncology

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology

How Artificial Intelligence Is Transforming Cancer Care in 2025: Diagnosis, Treatment, Clinical Trials, and Screening

Inside ASCO25 Exhibition - Who did it the best?

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Insight

Jun 13, 2025, 04:29

MD Anderson Research Highlights

Drugs

Jun 13, 2025, 04:16

Pemigatinib (Pemazyre): Uses in Cancer, Side effects, Dosage, Expectation and more

Insight

Jun 13, 2025, 03:49

Diego A. Díaz García shared an article on roles of the gut microbiota in immune-related adverse events - mechanisms and therapeutic intervention

Oncolibrary

Jun 13, 2025, 03:18

Etiology: Understanding the Causes and Origins of Disease

Insight

Jun 12, 2025, 19:31

Amar Kishan: UCLA Launches ILLUSION Trial on 2 mm PTV Margins in CT-Guided SBRT

Insight

Jun 12, 2025, 19:16

Eric K. Singhi: U.S. FDA Approved Taletrectinib for ROS1+ mNSCLC

Insight

Jun 12, 2025, 19:07

Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials

Blog

Jun 12, 2025, 18:57

Edward Christopher Dee and Layal Al Mahmasani Highlighted Participation in Inaugural Global Oncology Trainee Track at MSK

Blog

Jun 12, 2025, 18:40

Blog

Jun 12, 2025, 18:30

ESMO Daily Reporter Interviewed Paolo Tarantino on ADCs in Breast Cancer Care

Insight

Jun 12, 2025, 18:22

Bruna Pellini: Chemotherapy Plus Anti-PD-1 or Anti-PD-L1 in Advanced PD-L1-Negative sqNSCLC

Insight

Jun 12, 2025, 18:16

Françoise Meunier Highlighted Study on Five-Year Survival in Young Breast Cancer Patients